Startup | February 27, 2024
Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
The aim is to strengthen industry-academia cooperation
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
Subscribe To Our Newsletter & Stay Updated
